Olink Holding AB (publ)

About Olink Holding AB (publ)

Olink, part of Thermo Fisher Scientific, is a company focused on advancing proteomics through innovative technologies and solutions. Their mission is to empower biomarker discovery and protein analysis with high-throughput, NGS-based proteomics platforms to uncover meaningful insights for research and drug development.

Products & Services

Olink Explore Series:A product line for high-throughput proteomics analysis.

Olink Reveal:Powerful NGS-based proteomics tool to uncover meaningful insights effortlessly.

Olink Target Series:Targeted proteomics panels for specific biomarker analysis, including Target 48 Neurodegeneration for research in neurodegenerative diseases.

Olink Flex:Flexible proteomics solution for customized biomarker studies.

Olink Focus:Focused proteomics tool for specific research needs.

Olink Concordance Test:A test to ensure consistency in proteomics data.

Olink Signature Q100:An instrument for proteomics analysis.

Olink Insight:A bioinformatic app for experiment planning, study design, and data analysis.

Olink Analyze:Software for analyzing proteomics data.

Specialties

Proteomics Biomarker Discovery High-Throughput Protein Analysis Neurodegeneration Research Population-Scale Proteogenomics Drug Development

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering T: - FT: Public Offering	A: 85000000 MR: - FA: 85,000,000 USD FAN: 85000000	D: 2023-01-18 FD: 2023-01-18	4 investors
2	RT: Public Offering T: - FT: Public Offering	A: 4250000 MR: - FA: 4,250,000 ADSs FAN: 4250000	D: 2023-01-18 FD: 2023-01-18	4 investors

Public Offering Latest

2023-01-18

$85.0M

4 investors (Pro only)

Public Offering 2023-01-18

$4.2M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Ryan Dhindsa

Doctor

Recent News